Literature DB >> 19100385

Intestinal ischemia/reperfusion injury triggers activation of innate toll-like receptor 4 and adaptive chemokine programs.

M J Watson1, B Ke, X-D Shen, F Gao, R W Busuttil, J W Kupiec-Weglinski, D G Farmer.   

Abstract

BACKGROUND: Ischemia/reperfusion injury (IRI) is a major problem in intestinal transplantation. Toll-like receptor 4 (TLR4) has been implicated as a possible link between the innate and adaptive immune systems, however little data exists regarding TLR4 in intestinal IRI. The goal of this study is to evaluate the involvement of TLR4 in intestinal IRI and to assess the effect on T cell related chemokine programs.
METHODS: C57BL6 mice underwent 100 minutes of warm intestinal ischemia by SMA clamping. Control WT mice underwent laparotomy without vascular occlusion. Separate survival and analysis groups were performed, and intestinal tissue was harvested at 1 hour, 2 hours, 4 hours, and 24 hours post-reperfusion. Analysis included histology, CD3 immunostaining, myeloperoxidase activity, Western blot, and PCR.
RESULTS: Survival was significantly worse in the IRI group vs control (50% vs. 100%). IRI caused severe histopathological injury including mucosal erosions and villous congestion and hemorrhage. Myeloperoxidase activity increased in a time-dependent manner after IRI (2.71 0.25 at 1 hour, 2.92 0.25 at 2 hours, 4 0.16 at 4 hours, 5.1 0.25 at 24 hours vs 0.47 0.11 controls, P < .05). Protein expression of TLR4 followed by NF-kappaB was increased after IRI. Additionally, mRNA production of IP-10, MIP-2, MCP-1, and RANTES was increased at all time-points, as was mRNA for ICAM-1 and E-selectin.
CONCLUSION: This study is the first to demonstrate increased expression of TLR4 and NF-kappaB after warm intestinal IRI. This detrimental cascade may be initiated by TLR4 via NF-kappaB signaling pathways, implicating TLR4 as a potential therapeutic target for the prevention of intestinal IRI.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19100385      PMCID: PMC2975481          DOI: 10.1016/j.transproceed.2008.07.144

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

Review 1.  Toll-like receptor control of the adaptive immune responses.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

Review 2.  The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation.

Authors:  Walter G Land
Journal:  Transplantation       Date:  2005-03-15       Impact factor: 4.939

Review 3.  Innate immunity and organ transplantation: the potential role of toll-like receptors.

Authors:  Cristiano Feijó Andrade; Thomas K Waddell; Shaf Keshavjee; Mingyao Liu
Journal:  Am J Transplant       Date:  2005-05       Impact factor: 8.086

4.  CD62 blockade with P-Selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation.

Authors:  Douglas G Farmer; Xiu-Da Shen; Farin Amersi; Dean Anselmo; Jeffrey P Ma; Bibo Ke; Feng Gao; Sarah Dry; Susan Fernandez; Gray D Shaw; Sue V McDiarmid; Ronald W Busuttil; Jerzy Kupiec-Weglinski
Journal:  Transplantation       Date:  2005-01-15       Impact factor: 4.939

Review 5.  Innate immunity: impact on the adaptive immune response.

Authors:  R Medzhitov; C A Janeway
Journal:  Curr Opin Immunol       Date:  1997-02       Impact factor: 7.486

6.  Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes.

Authors:  M Muzio; N Polentarutti; D Bosisio; M K Prahladan; A Mantovani
Journal:  J Leukoc Biol       Date:  2000-04       Impact factor: 4.962

7.  Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury.

Authors:  Douglas G Farmer; Dean Anselmo; Xiu Da Shen; Bibo Ke; Ian C Carmody; Feng Gao; Charles Lassman; Sue V McDiarmid; Grey Shaw; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Transplantation       Date:  2005-09-27       Impact factor: 4.939

8.  Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway.

Authors:  Yuan Zhai; Xiu-da Shen; Ryan O'Connell; Feng Gao; Charles Lassman; Ronald W Busuttil; Genhong Cheng; Jerzy W Kupiec-Weglinski
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

9.  The two faces of IKK and NF-kappaB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion.

Authors:  Lee-Wei Chen; Laurence Egan; Zhi-Wei Li; Florian R Greten; Martin F Kagnoff; Michael Karin
Journal:  Nat Med       Date:  2003-04-07       Impact factor: 53.440

  9 in total
  12 in total

Review 1.  Intestinal ischemia/reperfusion: microcirculatory pathology and functional consequences.

Authors:  Brigitte Vollmar; Michael D Menger
Journal:  Langenbecks Arch Surg       Date:  2010-11-19       Impact factor: 3.445

2.  Gut Microbiota Restricts NETosis in Acute Mesenteric Ischemia-Reperfusion Injury.

Authors:  Stefanie Ascher; Eivor Wilms; Giulia Pontarollo; Henning Formes; Franziska Bayer; Maria Müller; Frano Malinarich; Alexandra Grill; Markus Bosmann; Mona Saffarzadeh; Inês Brandão; Kathrin Groß; Klytaimnistra Kiouptsi; Jens M Kittner; Karl J Lackner; Kerstin Jurk; Christoph Reinhardt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-07-02       Impact factor: 8.311

3.  Identification and validation of biomarkers associated with acute and chronic graft versus host disease.

Authors:  S S Ahmed; X N Wang; J Norden; K Pearce; E El-Gezawy; S Atarod; I Hromadnikova; M Collin; E Holler; A M Dickinson
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

4.  Murine Model of Intestinal Ischemia-reperfusion Injury.

Authors:  Ekaterina O Gubernatorova; Ernesto Perez-Chanona; Ekaterina P Koroleva; Christian Jobin; Alexei V Tumanov
Journal:  J Vis Exp       Date:  2016-05-11       Impact factor: 1.355

5.  MicroRNA-146a-mediated downregulation of IRAK1 protects mouse and human small intestine against ischemia/reperfusion injury.

Authors:  Cécilia Chassin; Cordelia Hempel; Silvia Stockinger; Aline Dupont; Joachim F Kübler; Jochen Wedemeyer; Alain Vandewalle; Mathias W Hornef
Journal:  EMBO Mol Med       Date:  2012-11-09       Impact factor: 12.137

Review 6.  Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia.

Authors:  Sanae Ben Mkaddem; Marcelle Bens; Alain Vandewalle
Journal:  Oncotarget       Date:  2010-12

7.  Innate immunity and transplantation tolerance: the potential role of TLRs/NLRs in GVHD.

Authors:  Ok S Shin; Jason B Harris
Journal:  Korean J Hematol       Date:  2011-06-21

8.  Therapeutic targeting of extracellular DNA improves the outcome of intestinal ischemic reperfusion injury in neonatal rats.

Authors:  Michael Boettcher; Georg Eschenburg; Stefan Mietzsch; Miguel Jiménez-Alcázar; Michaela Klinke; Deirdre Vincent; Bastian Tiemann; Robert Bergholz; Konrad Reinshagen; Tobias A Fuchs
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

9.  Pretreatment with the ALDH2 agonist Alda-1 reduces intestinal injury induced by ischaemia and reperfusion in mice.

Authors:  Qiankun Zhu; Guizhen He; Jie Wang; Yukang Wang; Wei Chen
Journal:  Clin Sci (Lond)       Date:  2017-03-21       Impact factor: 6.124

10.  C-C Chemokine Ligand-5 is critical for facilitating macrophage infiltration in the early phase of liver ischemia/reperfusion injury.

Authors:  Chiou-Mei Lee; Hsin-Hsin Peng; Polung Yang; Jiin-Tarng Liou; Chia-Chih Liao; Yuan-Ji Day
Journal:  Sci Rep       Date:  2017-06-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.